Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Jean Michaud

Sports Medicine Caribou, ME Medical Doctor

NPI 1295752657 CMS profile 542897

163 Van Buren Rd, Orthopedic Services, Caribou, ME 04736

Open in the dashboard

General payments

$1,486

29 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Jean Michaud of Caribou, ME is reported in the CMS Open Payments database as having received $1,486 across 29 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 23rd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $126 2
2023 General $185 4
2022 General $261 6
2021 General $402 7
2020 General $160 4
2019 General $352 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jean Michaud
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Jean Michaud were reported at $0. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Jean Michaud Sports Medicine median Middle half National median
2019 $352 $1,176 $199–$4,249 $163
2020 $160 $708 $96–$2,890 $114
2021 $402 $1,213 $152–$3,994 $132
2022 $261 $1,230 $159–$3,998 $149
2023 $185 $584 $146–$2,836 $160
2024 $126 $628 $163–$3,168 $164
2025 $0 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Zimmer Biomet Holdings, Inc. $1,143 15 payments
  2. E.R. Squibb & Sons, L.L.C. $133 9 payments
  3. Pfizer Inc. $104 1 payment
  4. Stryker Corporation $92 3 payments
  5. Djo, LLC $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,197 27 payments
  2. Education $289 2 payments
Products named General payments · program years 2019–2024
  1. Knees-None $347 3 payments
  2. Persona Knees $319 3 payments
  3. Hips-None $253 2 payments
  4. Persona Knees $173 3 payments
  5. Persona Knees $162 2 payments
  6. ELIQUIS Cardiovascular $133 9 payments
  7. Knees Product Portfolio $119 1 payment
  8. Avenir $113 2 payments
  9. ELIQUIS Cardiovascular;Metabolic Disease $104 1 payment
  10. ECHO $81 1 payment
  11. Other $336 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$81,848

Of which drugs: $17,348

Medicare patients

235

Average age 76

Services billed

18,936

151 women, 84 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Ischemic heart disease 31%
Atrial fibrillation 22%
COPD 20%
Depression 19%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 24 38 $14,898
Injection, methylprednisolone acetate, 1 mg J1010 Office 132 18,083 $1,792
Injection, methylprednisolone acetate, 40 mg J1030 Office 92 230 $467

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

29 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record